Sr One Capital Management as of June 30, 2026
Portfolio Holdings for Sr One Capital Management
Sr One Capital Management holds 15 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Veradermics Common Stock (MANE) | 28.4 | $295M | 2.4M | 122.94 | |
| Zenas BioPharma Common Stock (ZBIO) | 12.3 | $128M | 5.0M | 25.38 | |
| CRISPR Therapeutics Common Shares (CRSP) | 10.7 | $111M | 2.0M | 54.54 | |
| Avalyn Pharma Common Stock | 10.5 | $109M | 3.3M | 32.92 | |
| Design Therapeutics Common Stock (DSGN) | 9.1 | $94M | 6.5M | 14.47 | |
| Odyssey Therapeutics Common Stock | 6.8 | $71M | 3.8M | 18.71 | |
| Alumis Common Stock (ALMS) | 5.3 | $55M | 2.0M | 28.14 | |
| ORIC Pharmaceuticals Common Stock (ORIC) | 4.8 | $50M | 4.6M | 10.83 | |
| Mineralys Therapeutics Common Stock (MLYS) | 4.1 | $42M | 1.6M | 26.98 | |
| ARS Pharmaceuticals Common Stock (SPRY) | 3.1 | $32M | 4.0M | 8.01 | |
| Mobia Medical Common Stock | 2.6 | $27M | 2.0M | 13.40 | |
| Nkarta Common Stock (NKTX) | 0.9 | $9.4M | 3.3M | 2.83 | |
| Oculis Holding Ordinary Shares (OCS) | 0.9 | $8.9M | 641k | 13.87 | |
| Ultragenyx Pharmaceutical Common Stock (RARE) | 0.4 | $4.6M | 138k | 33.39 | |
| enGene Holdings Common Shares | 0.1 | $1.3M | 748k | 1.73 |
